Prognostic value of hyperuricemia in patients with heart failure

Prognostic value of hyperuricemia in patients with heart failure

Authors

  • Ketevan Sanikidze Tbilisi State Medical University image/svg+xml
  • Irma Mamatsashvili Tbilisi State Medical University image/svg+xml
  • Shalva Petriashvili

DOI:

https://doi.org/10.52340/spectri.2023.16

Keywords:

heart failure, hyperuricemia, sensitivity, specificity, prognostic value

Abstract

In patients with heart failure, hyperuricemia is often observed. The purpose of our study is to determine the relationship of serum uric acid with biochemical characteristics of heart failure and to determine its diagnostic and prognostic value for the outcome of the disease.

Material and methods: the study was based on the results of the study of 117 patients with asymptomatic hyperuricemia who applied to the clinic from September 2019 to January 2022. We determined the relationship between serum uric acid and the characteristics of heart failure, using ROCK analysis we determined the sensitivity and specificity of uric acid for the outcome of heart failure.

Results: Creatinine - r=0.478**, p=0.000 shows a reliable positive correlation with uric acid concentration; CRP - r=0.742**, p=0.000; BNP - r=0.599**, p=0.000, and eGFR - r=-0.184*, p=0.046 shows a reliable negative correlation; According to the degree of heart failure, the concentration of uric acid was distributed as follows: NYHAI - 5.48+0.94; NYHAII - 6.71+1.36; NYHAIII - 8.10+1.14; NYHA IV - 8.78+1.01 (F=29.24, p<0.0001). sensitivity - 00.810(95%CI: 0.709-0.911); specificity - 0.814(95%CI: 0.714-0.913); predictive value of negative result 0.814(95%CI:0.714-0.913); Prognostic value of a positive result - 0.810(95%CI:0.709-0.911); Diagnostic accuracy of the test - 0.812(95%CI:0.741-0.883).

Conclusions:

Serum uric acid values correlate with renal function and heart failure characteristics.

The value of uric acid can be used as an additional test to predict the outcome of heart failure.

Downloads

Download data is not yet available.

Author Biographies

Ketevan Sanikidze, Tbilisi State Medical University

PhD student

Irma Mamatsashvili, Tbilisi State Medical University

Assoc. Professor

Shalva Petriashvili

Professor  

References

Savarese G, Becher PM, Lund LH, Seferovic P, Rosano G, Coats AJ. Global burden of heart failure: a comprehensive and updated review of epidemiology. Cardiovascular Research. 2022 Feb 12.

Kojima S, Sakamoto T, Ishihara M, Kimura K, Miyazaki S, Yamagishi M, Tei C, Hiraoka H, Sonoda M, Tsuchihashi K, Shimoyama N. Prognostic usefulness of serum uric acid after acute myocardial infarction (the Japanese Acute Coronary Syndrome Study). The American journal of cardiology. 2005 Aug 15;96(4):489-95.

Hamaguchi S, Furumoto T, Tsuchihashi-Makaya M, Goto K, Goto D, Yokota T, Kinugawa S, Yokoshiki H, Takeshita A, Tsutsui H, JCARE-CARD Investigators. Hyperuricemia predicts adverse outcomes in patients with heart failure. International journal of cardiology. 2011 Sep 1;151(2):143-7.

Ford ES, Li C, Cook S, Choi HK. Serum concentrations of uric acid and the metabolic syndrome among US children and adolescents. Circulation 2007; 115: 2526– 2532.

Huang H, Huang B, Li Y, Huang Y, Li J, Yao H, Jing X, Chen J, Wang J. Uric acid and risk of heart failure: a systematic review and meta‐analysis. European journal of heart failure. 2014 Jan;16(1):15-24.

Gustafsson D, Unwin R. The pathophysiology of hyperuricaemia and its possible relationship to cardiovascular disease, morbidity and mortality. BMC nephrology. 2013 Dec;14(1):1-9.

Jankowska EA, Ponikowska B, Majda J, Zymlinski R, Trzaska M, Reczuch K, Borodulin-Nadzieja L, Banasiak W, Ponikowski P. Hyperuricaemia predicts poor outcome in patients with mild to moderate chronic heart failure. International journal of cardiology. 2007 Feb 7;115(2):151-5.

Madero M, Sarnak MJ, Wang X, Madero M, Sarnak MJ, Wang X, Greene T, Beck GJ, Kusek JW, Collins AJ, Levey AS, Menon V. Uric acid and long-term outcomes in CKD. Am J Kidney Dis 2009; 53: 796– 803.

Iseki K, Ikemiya Y, Inoue T, Iseki C, Kinjo K, Takishita S. Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort. American Journal of Kidney Diseases. 2004 Oct 1;44(4):642-50.

Sanikidze Q, Mamacashvili I, Petriashvili S. PREVALENCE OF HYPERURICEMIA IN PATIENTS WITH CHRONIC HEART FAILURE. Georgian Medical News. 2021 Feb 1(311):85-8.

Hamaguchi S, Furumoto T, Tsuchihashi-Makaya M, Goto K, Goto D, Yokota T, Kinugawa S, Yokoshiki H, Takeshita A, Tsutsui H, JCARE-CARD Investigators. Hyperuricemia predicts adverse outcomes in patients with heart failure. International journal of cardiology. 2011 Sep 1;151(2):143-7.

Downloads

Published

2023-03-10

How to Cite

Sanikidze, K., Mamatsashvili, I., & Petriashvili, S. (2023). Prognostic value of hyperuricemia in patients with heart failure. Scientific Journal „Spectri“, 1. https://doi.org/10.52340/spectri.2023.16

Issue

Section

Articles
Loading...